Today: 19 May 2026
Browse Category

BSE:CANBK 2 December 2025

Canara Bank Share Price Today: Stock Near ₹154 at New 52‑Week High on Strong Q2 Earnings and PSU Bank Rally

Canara Bank Share Price Today: Stock Near ₹154 at New 52‑Week High on Strong Q2 Earnings and PSU Bank Rally

Canara Bank stock hit a 52-week high near ₹154 on 2 December 2025, nearly doubling from its low of ₹78.6 over the past year. Shares closed around ₹153.6–₹153.9 on traded volumes above 2 crore. The rally followed Q2 FY26 results showing net profit up 18–19% year-on-year to about ₹4,774 crore, with improved asset quality and lower credit costs.
2 December 2025
··

Stock Market Today

  • Options Market Signals Possible Volatility in Alamos Gold Stock
    May 19, 2026, 9:56 AM EDT. Investors should watch Alamos Gold Inc. (AGI) as options trading shows high implied volatility in the February 2026 $48 put, indicating expectations of significant stock price movement. Implied volatility measures market anticipation of future price swings. Despite this, analysts hold a cautious view with a Zacks Rank #3 (Hold) and have downgraded quarterly earnings estimates from 56 cents to 49 cents per share. The mining firm resides in a top 20% industry rank but faces mixed outlooks. Seasoned traders might use these volatility signals to sell options premium, betting on lower-than-expected price moves by expiration. This divergence between options market expectations and analyst forecasts suggests potential trading opportunities, highlighting the need for careful investor attention.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

19 May 2026
NextEra Energy shares fell 4.6% to $89.04 late Monday after announcing a $66.8 billion stock-led merger with Dominion Energy, whose shares rose 9.4% to $67.56. The deal would create one of the world’s largest electric utilities, serving about 10 million customer accounts and owning 110 gigawatts of generation across four states.
Go toTop